Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation
Condition(s):Atrial Fibrillation; InflammationLast Updated:February 16, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Atrial Fibrillation; InflammationLast Updated:February 16, 2022Completed
Condition(s):Cardiovascular Disease; Atrial Fibrillation; StrokeLast Updated:October 22, 2019Active, not recruiting
Condition(s):Atrial FibrillationLast Updated:April 10, 2017Completed
Condition(s):Atrial Fibrillation; Atrial TachyarrhythmiaLast Updated:February 8, 2017Completed
Condition(s):Atrial Fibrillation; Renal Insufficiency; CardioversionLast Updated:August 7, 2019Unknown status
Condition(s):Atrial Fibrillation Paroxysmal; RecurrenceLast Updated:April 14, 2022Recruiting
Condition(s):Paroxysmal Atrial FibrillationLast Updated:February 21, 2019Completed
Condition(s):Atrial FibrillationLast Updated:October 13, 2021Enrolling by invitation
Condition(s):Atrial FibrillationLast Updated:May 8, 2020Completed
Condition(s):Atrial Fibrillation – SymptomaticLast Updated:April 6, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.